Last Price
1.70
Today's Change
+0.05 (3.03%)
Day's Change
1.65 - 1.75
Trading Volume
4,433,136
Market Cap
418 Million
Shares Outstanding
246 Million
Avg Volume
4,571,139
Avg Price (50 Days)
2.14
Avg Price (200 Days)
1.68
PE Ratio
-2.12
EPS
-0.80
Earnings Announcement
02-May-2024
Previous Close
1.65
Open
1.73
Day's Range
1.65 - 1.75
Year Range
0.92 - 3.79
Trading Volume
4,431,136
1 Day Change
3.03%
5 Day Change
9.68%
1 Month Change
-23.08%
3 Month Change
-20.19%
6 Month Change
21.43%
Ytd Change
6.92%
1 Year Change
-28.57%
3 Year Change
-64.88%
5 Year Change
-71.99%
10 Year Change
-84.13%
Max Change
-98.70%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.